Fundraising Fox
/Companies
Sign in

Intrinsic Therapeutics

Woburn, US · Founded 2000 · Delaware corporation · 85 employees on LinkedIn · 5 known investors

Find your way into Intrinsic Therapeutics

Sign up to see every warm intro you have to Intrinsic Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Intrinsic Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects. The device is marketed to physicians and patients with lumbar disc herniation.

HealthtechMedical Devices

Founders & leadership

Intrinsic Therapeutics was founded in 2000 by Gregory H. Lambrecht.

GH
Gregory H. LambrechtFounder
CH
Carey HaganExecutive
CH
Cary HaganExecutive

Board

RDRyan Drant
Ryan DrantBoard directorFounder and Managing Partner at Questa Capital
JD
Jeani DelagardelleBoard directorVenture Partner at New Leaf Venture Partners
JM
Joshua MakowerBoard directorGeneral Partner at New Enterprise Associates (NEA)
BV
Brian VerrierBoard director
KS
Kevin SidowBoard director
KC
Kevin ConnorsBoard director

Investors · 5

New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M

How we know: board seat on SEC Form D · Not right? Tell us

Questa Capitallisted by Questa CapitalSan Francisco · $15M – $40Mvia Ryan Drant · board

How we know: Questa Capital's portfolio page · board seat on SEC Form D · funding news · Not right? Tell us

Greenspring AssociatesreportedPortland

How we know: funding news · Not right? Tell us

New Leaf Venture PartnersinferredNew Yorkvia Jeani Delagardelle · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$189.8M disclosed across 7 rounds · 2014–2023

▶$55.5MraisedDec 2023 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeani DeagardellelDirector
  • Gregory H. LambrechtDirector
  • Ryan DrantDirector
  • Cary HaganExecutive Officer, Director
  • Peter PizzoExecutive Officer
  • Brian VerrierDirector
Offering amount
$68.5M
Amount sold
$55.5M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedAug 2023 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin SidowDirector
  • Gregory H. LambrechtDirector
  • Ryan DrantDirector
  • Brian VerrierDirector
  • Peter PizzoExecutive Officer
  • Jeani DelagardelleDirector
  • Cary HaganExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$5.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedApr 2023 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian VerrierDirector
  • Gregory LambrechtDirector
  • Kevin SidowDirector
  • Jeani DelagardelleDirector
  • Ryan DrantDirector
  • Cary HaganExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$5.9M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.4MraisedApr 2021 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan DrantDirector
  • Jeani DelagardelleDirector
  • Gregory H. LambrechtDirector
  • Brian VerrierDirector
  • Joshua MakowerDirector
  • Carey HaganExecutive Officer, Director
  • Kevin SidowDirector
Offering amount
$40M
Amount sold
$38.4M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.8MraisedApr 2019 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan DrantDirector
  • Joshua MakowerDirector
  • Brian VerrierDirector
  • Kevin SidowDirector
  • Jeani DelagardelleDirector
  • Gregory H LambrechtExecutive Officer, Director
  • Cary HaganExecutive Officer, Director
  • Kevin ConnorsDirector
Offering amount
$41.7M
Amount sold
$38.8M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.4MraisedMar 2017 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory H LambrechtExecutive Officer, Director
  • Cary HaganExecutive Officer, Director
  • Ryan DrantDirector
  • Kevin SidowDirector
  • Brian VerrierDirector
  • Jeani DelagardelleDirector
  • Kevin ConnorsDirector
  • Joshua MakowerDirector
Offering amount
$28.4M
Amount sold
$28.4M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.3MraisedSep 2014 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin SidowDirector
  • Kevin ConnorsDirector
  • Brian VerrierDirector
  • Joshua MakowerDirector
  • Gregory H. LambrechtExecutive Officer, Director
  • Jeani DelagardelleDirector
  • Cary HaganExecutive Officer, Director
  • Ryan DrantDirector
Offering amount
$20.9M
Amount sold
$17.3M
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patientsprnewswire.com · Apr 2019

Frequently asked questions

What does Intrinsic Therapeutics do?
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects. The device is marketed to physicians and patients with lumbar disc herniation.
Who founded Intrinsic Therapeutics?
Intrinsic Therapeutics was founded by Gregory H. Lambrecht in 2000.
Who are Intrinsic Therapeutics's investors?
Intrinsic Therapeutics's investors include Delos Capital, New Enterprise Associates (NEA), Questa Capital, Greenspring Associates, New Leaf Venture Partners.
How much funding has Intrinsic Therapeutics raised?
Intrinsic Therapeutics has disclosed $189.8M raised across 7 rounds.
Where is Intrinsic Therapeutics headquartered?
Intrinsic Therapeutics is headquartered in Woburn, US.